Affiliation:
1. The Departments of Biology, University of Waterloo School of Pharmacy, Kitchener, ON, N2G IC5, Canada
2. Faculty of Science, and the School of Public Health and Health Systems, Faculty of Applied Health Science, University of Waterloo School of Pharmacy, Kitchener, ON, N2G IC5, Canada
Abstract
Background:
PDGFβ receptors and their ligand, PDGF-BB, are upregulated in vivo after neuronal
insults such as ischemia. When applied exogenously, PDGF-BB is neuroprotective against excitotoxicity
and HIV proteins.
Objective:
Given this growth factor's neuroprotective ability, we sought to determine if PDGF-BB would
be neuroprotective against amyloid-β (1-42), one of the pathological agents associated with Alzheimer's
disease (AD).
Methods and Results:
In both primary hippocampal neurons and the human-derived neuroblastoma cell
line, SH-SY5Y, amyloid-β treatment for 24 h decreased surviving cell number in a concentrationdependent
manner. Pretreatment with PDGF-BB failed to provide any neuroprotection against amyloid-β
in primary neurons and only very limited protective effects in SH-SY5Y cells. In addition to its neuroprotective
action, PDGF promotes cell growth and division in several systems, and the application of PDGFBB
alone to serum-starved SH-SY5Y cells resulted in an increase in cell number. Amyloid-β attenuated
the mitogenic effects of PDGF-BB, inhibited PDGF-BB-induced PDGFβ receptor phosphorylation, and
attenuated the ability of PDGF-BB to protect neurons against NMDA-induced excitotoxicity. Despite the
ability of amyloid-β to inhibit PDGFβ receptor activation, immunoprecipitation experiments failed to
detect a physical interaction between amyloid-β and PDGF-BB or the PDGFβ receptor. However, G
protein-coupled receptor transactivation of the PDGFβ receptor (an exclusively intracellular signaling
pathway) remained unaffected by the presence of amyloid-β.
Conclusions:
As the PDGF system is upregulated upon neuronal damage, the ability of amyloid-β to
inhibit this endogenous neuroprotective system should be further investigated in the context of AD
pathophysiology.
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Neurology,Neurology
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献